1037 GMT - Major pharmaceutical stocks GSK and AstraZeneca, alongside aerospace and defense stocks Rolls-Royce and Melrose, are among the biggest FTSE 100 fallers ahead of Trump's tariff announcement later Wednesday. These stocks would be "in the firing line if Trump doesn't give the U.K. special treatment," says AJ Bell's Russ Mould in a note. Many investors hope the U.K. could be spared the worst of the tariffs. However, if U.K. Prime Minister Keir Starmer fails to secure a better deal, companies within pharma, food and drink, aviation, chemical and automotive sectors would be vulnerable, he says. Rolls-Royce is the biggest FTSE 100 faller, down 3.4%; GSK falls 3.2%; Melrose loses 2.6% and AstraZeneca is down 2.3%. The FTSE 100 falls 0.7%. (jessica.fleetham@wsj.com)
(END) Dow Jones Newswires
April 02, 2025 06:37 ET (10:37 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。